Published Studies Provide Further Support For Kalytera’s Program Evaluating CBD in GVHD

SAN FRANCISCO and TEL AVIV, Israel, Nov. 22, 2019 (GLOBE NEWSWIRE) — Kalytera Therapeutics, Inc. (TSX VENTURE: KLY and OTCQB: KALTF) (the “Company” or “Kalytera”) today announced that research reported in two peer-reviewed articles published in Blood provide further evidence supporting the activity of cannabidiol (“CBD”) in prevention and treatment of acute graft versus host …

Humble Flower Debuts Elevated New Branding Following Indus Holdings, Inc. Acquisition

LOS ANGELES, Nov. 19, 2019 /PRNewswire/ — Luxury hemp-based CBD and cannabis-infused topical brand, Humble Flower, debuts its new, elevated look and revamped website following its May 8th acquisition by the leading vertically integrated cannabis company, Indus Holdings, Inc. (CNSX:INDS). Humble Flower focused its third quarter efforts on rebranding the products’ packaging and website to …

Veritas Farms Receives Award for Upcoming Line of Full Spectrum CBD Pet Products

Fort Lauderdale, FL, Nov. 19, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Veritas Farms, Inc. (OTCQB:VFRM) (“Veritas Farms” or the “Company”), a vertically integrated agribusiness focused on the production of full spectrum hemp oil products with naturally occurring cannabinoids, is pleased to announce that they unveiled their upcoming line of full spectrum hemp oil infused …

CBD Beauty Brand Cannuka to Participate in Cowen’s 2nd Annual Cannabis Conference in Boston

Cincinnati, Ohio, Nov. 08, 2019 (GLOBE NEWSWIRE) — Cannuka, LLC (“Cannuka” or the “Company”), a leading cannabidiol (“CBD”) beauty and skincare brand, today announced that Ransley Carpio, the Company’s Chief Executive Officer, will participate on the CBD In Retail panel at Cowen’s 2nd Annual Boston Cannabis Conference being held on November 11th, 12th, and 13th, 2019 at …

clēēn:craft: A New Way to Experience CBD Beverages

SEATTLE, Sept. 30, 2019 /PRNewswire/ — clēēn:craft announced today the nationwide launch of its carbonated ready-to-drink adult alternative beverages. clēēn:craft is THC-free, utilizes 2 mg of full-spectrum hemp extract per ounce and all-natural juices, resulting in sparkling beverages with premium taste and effect. Designed to “power your mood”™, clēēn:craft premium beverages were created and are …

5 Best CBD Products for Cats Available on Amazon

One of the biggest rising trends within the feline animal and pet health industries is undoubtedly cannabidiol, a.k.a. CBD. While Amazon was slow to begin offering CBD products for cats, they finally do, so Prime members and cat lovers everywhere can rejoice.  Cannabidiol for Cats According to Dr. Angie Krause, DVM, CVA, CCRT, founder of …

cbdMD Announces Partnership with Ultra Sport Europe in the U.K. and Ireland

CHARLOTTE, N.C., Aug. 13, 2019 /PRNewswire/ — cbdMD, Inc., a nationally recognized consumer cannabidiol (CBD) brand (NYSE American: YCBD), has announced its comprehensive partnership with European-based distribution company, Ultra Sport EU. As one of the industry’s leading CBD brands, cbdMD has a unique approach separating themselves from many others in the space. Partnering with professional …

CV Sciences, Inc. CEO Issues Letter to Shareholders

SAN DIEGO, Aug. 12, 2019 (GLOBE NEWSWIRE) — CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products through its industry-dominating brand, PlusCBD™ Oil, today released a letter to shareholders from CEO Joseph Dowling. Dear Shareholders, Last week we issued our second quarter …

Using CBD Has Never Been More Popular For Americans

Whatever notions that CBD was just another wellness fad are officially dead. Need proof? Look no further than a Gallup poll released earlier this week. According to the poll, one in every seven Americans now use CBD for its therapeutic benefits. While federal regulations around CBD remain unsettled for now, the legalization of hemp in …

Tilray® Imports GMP-Certified CBD into the U.S. for Two Clinical Trials Led by NYU School of Medicine

NANAIMO, British Columbia–(BUSINESS WIRE)–Tilray, Inc. (NASDAQ:TLRY), a global pioneer in cannabis research, cultivation, production, and distribution, today announced it has received approval from the U.S. government and successfully imported an initial shipment of medical cannabinoids into the U.S. to support two clinical trials led by NYU School of Medicine. The two studies will test the …